Lifeward Ltd. current report, 02 May 2018

Business Context and Reporting Period

This Form 8-K filing by ReWalk Robotics Ltd. (noted as Lifeward Ltd. in metadata) is dated May 2, 2018. The report discloses corporate governance changes, specifically the appointment of a new director and Audit Committee Chairman to fill a vacancy left by a prior resignation.

Key Financial Metrics

The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It is a current report focused on personnel changes rather than financial performance.

Material Changes

  • Board Appointment: Yohanan Engelhardt was appointed to the Board of Directors effective May 2, 2018, replacing Glenn Muir, who resigned on December 29, 2017.
  • Committee Roles: Mr. Engelhardt was appointed to the Audit Committee and subsequently named Chairman of the Audit Committee on May 3, 2018.
  • Independence: The Board determined Mr. Engelhardt meets independence requirements under SEC rules and Nasdaq listing standards, including audit committee financial expert requirements.

Compensation and Outlook

While no financial guidance or outlook is provided, the filing details the compensatory arrangements for the new director:

  • Cash Retainer: NIS 83,480 (approx. $23,318) annually.
  • Meeting Fees: NIS 4,390 (approx. $1,226) per in-person meeting; 60% for telephonic meetings; 50% for written consents.
  • Equity Grant: Restricted Stock Units (RSUs) valued at $30,000 on the grant date, vesting quarterly over one year.
  • Future Grants: Annual RSU grants valued at $25,000 commencing with the 2019 annual general meeting.

Mr. Engelhardt brings experience as a former CFO of a publicly traded company and provides CFO-consulting services to early-stage technology and medical device firms.

Investor Verification Checklist

  • Verify the resignation details of former director Glenn Muir in the December 28, 2017 Form 8-K.
  • Confirm the vesting schedule and terms of the 2014 Equity Incentive Plan referenced for the RSU grants.
  • Review the press release (Exhibit 99.1) for additional context on the strategic rationale for the appointment.
  • Check subsequent filings for the 2019 annual general meeting to confirm the execution of future annual RSU grants.